MedPath

Lorzone

Approved
Approval ID

cd269b7c-3bcf-4caf-8f37-3724eea8256d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 18, 2017

Manufacturers
FDA

Lake Erie Medical DBA Quality Care Products LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

chlorzoxazone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55700-517
Application NumberANDA040861
Product Classification
M
Marketing Category
C73584
G
Generic Name
chlorzoxazone
Product Specifications
Route of AdministrationORAL
Effective DateApril 17, 2017
FDA Product Classification

INGREDIENTS (8)

DOCUSATE SODIUMInactive
Code: F05Q2T2JA0
Classification: IACT
CHLORZOXAZONEActive
Quantity: 375 mg in 1 1
Code: H0DE420U8G
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lorzone - FDA Drug Approval Details